Diethyl [(2-chloroethoxy)methyl]phosphonate | CAS:116384-56-6

We serve Diethyl [(2-chloroethoxy)methyl]phosphonate CAS:116384-56-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Diethyl [(2-chloroethoxy)methyl]phosphonate

Chemical Name: Diethyl [(2-chloroethoxy)methyl]phosphonate
CAS.NO: 116384-56-6
Synonyms:
Diethyl,(2-chloroethoxy)methyl)phosphonate
1-chloro-2-(diethoxyphosphorylmethoxy)ethane

Molecular Formula:C7H16ClO4P
Molecular Weight: 230.62600

Physical and Chemical Properties:
Density: 1.161g/cm3
Boiling point: 292.335ºC at 760 mmHg
Melting point:/
Flash point: 164.2±29.4 °C
Refractive index: 1.431

Specification:
Appearance:  White powder
Purity:≥98%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:
Intermediates of Adefovir dipivoxil CAS: 142340-99-6



Contact us for information like Diethyl [(2-chloroethoxy)methyl]phosphonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-chloro-2-(diethoxyphosphorylmethoxy)ethane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-chloro-2-(diethoxyphosphorylmethoxy)ethane Use and application,Diethyl [(2-chloroethoxy)methyl]phosphonate technical grade,usp/ep/jp grade.


Related News: Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.4-Amino-5-(ethylsulfonyl)-2-methoxybenzoic acid manufacturer The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.ethyl (1R,2S)-1-amino-2-ethenylcyclopropane-1-carboxylate,sulfuric acid supplier A number of UK citizens who failed to leave the coronavirus-struck Chinese city of Wuhan last week are now on a second flight to Europe, UK Foreign Secretary Dominic Raab said Sunday.1-(1,3-thiazol-2-yl)ethanone vendor But they’ll be subject to up to 14 days of mandatory quarantine once they’re back in the US.In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.